TGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia.
暂无分享,去创建一个
J. Soulier | A. D’Andrea | D. Kozono | M. Grompe | J. Greenberger | K. Parmar | Kevin W. O’Connor | L. Moreau | Haojian Zhang | G. Bagby | Alix Rousseau | Emily F. Gaudiano | Sofia L. Vidal-Cardenas | A. Hamilton
[1] J. Greenberger. TGF-B Inhibition Rescues Hematopoietic Defects in Fanconi Anemia , 2018, Blood.
[2] S. Karlsson,et al. TGF-β signaling in the control of hematopoietic stem cells. , 2015, Blood.
[3] David A. Williams,et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells , 2015, Nature.
[4] Martin Kircher,et al. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. , 2015, Cancer discovery.
[5] Mary Helen Barcellos-Hoff,et al. New tricks for an old fox: Impact of TGFβ on the DNA damage response and genomic stability , 2014, Science Signaling.
[6] Weiying Zhou,et al. TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes , 2014, Molecular Cancer Research.
[7] M. L. Beau,et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells , 2014, Nature.
[8] I. Weissman,et al. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. , 2014, Cell stem cell.
[9] Luigi Naldini,et al. Targeted gene therapy and cell reprogramming in Fanconi anemia , 2014, EMBO molecular medicine.
[10] B. Dawson,et al. Excessive TGFβ signaling is a common mechanism in Osteogenesis Imperfecta , 2014, Nature Medicine.
[11] A. Grinberg,et al. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis , 2014, Nature Medicine.
[12] A. D’Andrea,et al. FANCD2 activates transcription of TAp63 and suppresses tumorigenesis. , 2013, Molecular cell.
[13] G. Barosi,et al. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. , 2013, Blood.
[14] S. Rafii,et al. TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy , 2013, The Journal of experimental medicine.
[15] Molly C. Kottemann,et al. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks , 2013, Nature.
[16] K. J. Patel,et al. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function , 2012, Nature.
[17] J. Soulier,et al. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. , 2012, Cell stem cell.
[18] Michael R. Green,et al. The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells , 2012, Nature Genetics.
[19] Jeremy M. Stark,et al. RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells , 2012, Nucleic acids research.
[20] D. Ross,et al. NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. , 2012, Biochemical pharmacology.
[21] S. Cocklin,et al. Inhibition of homologous recombination in human cells by targeting RAD51 recombinase. , 2012, Journal of medicinal chemistry.
[22] Stephen J. Elledge,et al. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA damage response , 2012, Nature Cell Biology.
[23] H. Kurumizaka,et al. Direct Inhibition of TNF-α Promoter Activity by Fanconi Anemia Protein FANCD2 , 2011, PloS one.
[24] David J. Rawlings,et al. Tracking genome engineering outcome at individual DNA breakpoints , 2011, Nature Methods.
[25] K. J. Patel,et al. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice , 2011, Nature.
[26] Stephen C. West,et al. DNA interstrand crosslink repair and cancer , 2011, Nature Reviews Cancer.
[27] Derrick J. Rossi,et al. DNA damage response in adult stem cells: pathways and consequences , 2011, Nature Reviews Molecular Cell Biology.
[28] M. Bitzer,et al. Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. , 2011, Cancer research.
[29] David J Adams,et al. Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi Anemia , 2011, Nature Genetics.
[30] M. Grompe,et al. Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol. , 2010, Blood.
[31] D. Pellman,et al. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. , 2010, The Journal of clinical investigation.
[32] M. Warr,et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. , 2010, Cell stem cell.
[33] E. Domany,et al. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. , 2010, Cell stem cell.
[34] Z. Hořejší,et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. , 2010, Molecular cell.
[35] M. Sivasubramaniam,et al. Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway , 2010, Science.
[36] J. Kutok,et al. Hematopoietic Stem Cell Defects in Mice with Deficiency of Fancd2 or Usp1 , 2010, Stem cells.
[37] B. Alter,et al. Pathophysiology and management of inherited bone marrow failure syndromes. , 2010, Blood reviews.
[38] A. D’Andrea,et al. Mouse models of Fanconi anemia. , 2009, Mutation research.
[39] P. Andreassen,et al. Fanconi anemia proteins and endogenous stresses. , 2009, Mutation research.
[40] F. Rosselli,et al. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities , 2009, Nature Cell Biology.
[41] Michael J. Emanuele,et al. A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene , 2009, Cell.
[42] I. Hickson,et al. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis , 2009, Nature Cell Biology.
[43] L. Niedernhofer. DNA repair is crucial for maintaining hematopoietic stem cell function. , 2008, DNA repair.
[44] David A. Williams,et al. TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells , 2007 .
[45] A. Bhandoola,et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. , 2007, Cell stem cell.
[46] Irving L. Weissman,et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age , 2007, Nature.
[47] Keisuke Ito,et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells , 2006, Nature Medicine.
[48] C. Heldin,et al. BRCA2 and Smad3 synergize in regulation of gene transcription , 2002, Oncogene.
[49] U. Hellman,et al. Functional proteomics of transforming growth factor‐β1‐stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFβ1‐dependent regulation of DNA repair , 2002, The EMBO journal.
[50] M. Buchwald,et al. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. , 1998, Blood.
[51] R. Gale,et al. Hematologic Abnormalities in Fanconi Anemia: An International Fanconi Anemia Registry Study , 1994 .
[52] Akhurst,et al. Title Targeting the TGFβ signalling pathway in disease , 2012 .
[53] David A. Williams,et al. TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. , 2007, The Journal of clinical investigation.
[54] Serhiy Souchelnytskyi,et al. TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage. , 2005, Oncogene.